Browse All

Current Filters

CLEAR FILTER x

TITLE

Tuberous Sclerosis Complex (TSC)–Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCom Trial

Author:van Eeghen, Agnies   Wilson, Sarah M.L.   Thiele, Elizabeth A.   Roszkowski, Stevie   Dunaway-Bryant, Maria   Wajer, Kasia   Greco, Teresa   Stevens, Joanne   Moore-Ramdin, Lisa   de Vries, Petrus J.   

Session Name:S5: Clinical Epilepsy  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:S5.005  

Author Institution:Amsterdam University Medical Centers  Advisium, ’s Heeren Loo, Amsterdam, Netherlands  McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX  Massachusetts General Hospital, MA  Jazz Pharmaceuticals, Inc., MA  Jazz Pharmaceuticals, Inc., PA  Jazz Pharmaceuticals, UK Ltd., United Kingdom  Jazz Pharmaceuticals, Inc., Italy  Jazz Pharmaceuticals, Inc., Philadelphia, PA  Jazz Pharmaceuticals, UK Ltd., Southampton, United Kingdom  Centre for Autism Research in Africa, University of Cape Town, South Africa